CoChat

Inhibitors of poly(ADP‐ribose) polymerase‐1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats

Open access
Chiarugi, Alberto · 2002 · British Journal of Pharmacology
Cited by 87

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

In the presence of genotoxic stress poly(ADP‐ribose) polymerase‐1 (PARP‐1) leads to NAD+ and ATP depletion, participating in the pathogenesis of several disorders including inflammation. Accordingly, chemical inhibitors of PARP‐1 are efficacious anti‐inflammatories, albeit the underlying molecular mechanisms are still under debate. This study investigated the effect of the PARP‐1 inhibitors 6(5H)‐phenanthridinone and benzamide as well as that of benzoic acid, an inactive analogue of benzamide, on development of experimental allergic encephalomyelitis (EAE) in rats. Both 6(5H)‐phenanthridinone and benzamide attenuated development of EAE, reducing clinical score, neuroimmune infiltration and expression of inflammatory mediators such as inducible nitric oxide synthase, interleukin‐1β and ‐2, cyclooxygenase‐2, tumour necrosis factor‐α and interferon‐γ in the spinal cord of myelin‐immunized rats. Importantly, no evidence of NAD+ and ATP depletion as well as poly(ADP‐ribose) formation was detected in the spinal cord. By contrast, a robust formation of poly(ADP‐ribose) occurred in B‐ and T‐cell areas in lymph nodes of myelin‐immunized rats and was suppressed by the treatment with 6(5H)‐phenanthridinone and benzamide. In cultures of activated rat lymphocytes, 6(5H)‐phenanthridinone and benzamide reduced the DNA‐binding activity of NF‐κB and AP‐1 and transcription of pro‐inflammatory cytokines such as interleukin‐2, interferon‐γ and tumour necrosis factor‐α. Notably, benzoic acid did not reproduce the in vivo and in vitro effects of its parent compound. These findings indicate that PARP‐1 promotes transcriptional activation in lymphocytes and inhibitors of its enzymatic activity are useful for the treatment of autoimmune disorders of the central nervous system. British Journal of Pharmacology (2002) 137, 761–770. doi:10.1038/sj.bjp.0704934

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0704934

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Chiarugi, A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2002-11
Volume
137
Issue
6
Pages
761-770
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1990459210
Cited by
87
References
3
FWCI
2.58
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.